Cargando…
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
BACKGROUND: NT1014 is a novel biguanide and AMPK activator with a high affinity for the organic cation-specific transporters, OCT1 and OCT3. We sought to determine the anti-tumorigenic effects of NT1014 in human ovarian cancer cell lines as well as in a genetically engineered mouse model of high-gra...
Autores principales: | Zhang, Lu, Han, Jianjun, Jackson, Amanda L., Clark, Leslie N., Kilgore, Joshua, Guo, Hui, Livingston, Nick, Batchelor, Kenneth, Yin, Yajie, Gilliam, Timothy P., Gehrig, Paola A., Sheng, Xiugui, Zhou, Chunxiao, Bae-Jump, Victoria L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031332/ https://www.ncbi.nlm.nih.gov/pubmed/27655410 http://dx.doi.org/10.1186/s13045-016-0325-7 |
Ejemplares similares
-
Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer
por: Guo, Hui, et al.
Publicado: (2016) -
The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth
por: Roque, Dario R., et al.
Publicado: (2021) -
Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer
por: Jackson, Amanda L., et al.
Publicado: (2017) -
The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
por: Stine, Jessica E., et al.
Publicado: (2015) -
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer*
por: Qiu, Haifeng, et al.
Publicado: (2015)